| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $5.9B | — | — | — | — |
| Op. Income | $1.5B | — | — | — | — |
| Gross Margin | 32.3% | — | — | — | — |
| Net Margin | 14.5% | — | — | — | — |
| EPS (Diluted) | $3.66 | — | — | — | — |
| Free Cash Flow | -$752M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $5.9B |
| Cost of Revenue | $4.0B |
| GROSS PROFIT | $1.9B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $0 |
| Other Expenses | $420M |
| Operating Expenses | $420M |
| Cost & Expenses | $4.4B |
| OPERATING INCOME | $1.5B |
| Interest Income | $0 |
| Interest Expense | $616M |
| Other Income/Expenses | -$593M |
| INCOME BEFORE TAX | $898M |
| Income Tax Expense | $30M |
| Net Income from Continuing Ops | $868M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $856M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $856M |
| D&A | $1.2B |
| EBIT | $1.5B |
| EBITDA | $2.7B |
| EPS | $4 |
| EPS Diluted | $4 |
| Item | Amount |
|---|---|
| REVENUE | $5.9B |
| Cost of Revenue | $4.0B |
| GROSS PROFIT | $1.9B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $0 |
| Other Expenses | $420M |
| Operating Expenses | $420M |
| Cost & Expenses | $4.4B |
| OPERATING INCOME | $1.5B |
| Interest Income | $0 |
| Interest Expense | $616M |
| Other Income/Expenses | -$593M |
| INCOME BEFORE TAX | $898M |
| Income Tax Expense | $30M |
| Net Income from Continuing Ops | $868M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $856M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $856M |
| D&A | $1.2B |
| EBIT | $1.5B |
| EBITDA | $2.7B |
| EPS | $4 |
| EPS Diluted | $4 |
| Item | Amount |
|---|---|
| Net Income | $856M |
| Depreciation & Amortization | $1.2B |
| Stock-Based Compensation | $21M |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $125M |
| Change in Working Capital | -$119M |
| OPERATING CASH FLOW | $2.0B |
| Capital Expenditure | -$2.8B |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$336M |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $562M |
| NET CASH FROM INVESTING | -$2.6B |
| Net Debt Issuance | $1.1B |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | -$613M |
| Other Financing Activities | $6M |
| NET CASH FROM FINANCING | $522M |
| FREE CASH FLOW | -$752M |
| Net Change in Cash | -$3M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $25M |
| Short-Term Investments | $0 |
| Net Receivables | $624M |
| Inventory | $829M |
| Other Current Assets | $259M |
| TOTAL CURRENT ASSETS | $1.8B |
| PP&E (Net) | $26.4B |
| Goodwill | $2.3B |
| Intangible Assets | $0 |
| Long-Term Investments | $1.1B |
| Tax Assets | $1.5B |
| Other Non-Current Assets | $2.4B |
| TOTAL NON-CURRENT ASSETS | $33.6B |
| TOTAL ASSETS | $35.4B |
| Account Payables | $654M |
| Short-Term Debt | $2.2B |
| Deferred Revenue | $0 |
| Other Current Liabilities | $675M |
| TOTAL CURRENT LIABILITIES | $3.7B |
| Long-Term Debt | $13.1B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $3.7B |
| Other Non-Current Liabilities | $4.6B |
| TOTAL NON-CURRENT LIABILITIES | $21.5B |
| TOTAL LIABILITIES | $25.2B |
| Common Stock | $7.3B |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $3.0B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$18M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $10.2B |
| Minority Interest | $47M |
| TOTAL EQUITY | $10.3B |
| TOTAL LIABILITIES & EQUITY | $35.4B |
| Total Debt | $15.4B |
| Net Debt | $15.4B |
